3959-23-7

Basic information

• Product Name: (PHENYLSULPHONYL)ACETIC ACID
• Synonyms: RARECHEM AL BO 0222;(PHENYLSULPHONYL)ACETIC ACID;(PHENYLSULFONYL)ACETIC ACID;AKOS BC-3141;AKOS BBS-00002853;IFLAB-BB F2109-0039;2-(PHENYLSULFONYL)-ACETIC ACID;2-(Phenylsulphonyl)acetic acid
• CAS NO: 3959-23-7
• Molecular Formula: C₈H₈O₄S
• Molecular Weight: 200.21
• Mol File: 3959-23-7.mol
• Article Data: 55

Chemical Properties

• Melting Point: 112 °C
• Boiling Point: 452.2 °C at 760 mmHg
• Flash Point: 227.3 °C
• Appearance: /
• Density: 1.406 g/cm³
• Vapor Pressure: 5.77E-09mmHg at 25°C
• Refractive Index: 1.566
• PKA: pK1:2.44 (25°C)
• BRN: 2504376
• CAS DataBase Reference: (PHENYLSULPHONYL)ACETIC ACID(CAS DataBase Reference)
• NIST Chemistry Reference: (PHENYLSULPHONYL)ACETIC ACID(3959-23-7)
• EPA Substance Registry System: (PHENYLSULPHONYL)ACETIC ACID(3959-23-7)

Safety Data

• Hazard Codes: Xi
• Statements: 36/37/38
• Safety Statements: 26-36
• HazardClass: IRRITANT
• Hazardous Substances Data: 3959-23-7(Hazardous Substances Data)

Usage

Uses

(Phenylsulfonyl)acetic acid is used as pharmaceutical intermediates.

InChI:InChI=1/C8H8O4S/c9-8(10)6-13(11,12)7-4-2-1-3-5-7/h1-5H,6H2,(H,9,10)

Upstream product

• 5296-64-0 allyl phenyl thioether 
• 64-19-7 acetic acid 
• 3959-08-8 (phenylsulfinyl)acetic acid 
• 103-04-8 (phenylthio)acetic acid 
• 1360789-21-4 2-(phenylsulfonyl)-1-(2,2,6,6-tetramethylpiperidin-1-yl)ethanone 
• 108-98-5 thiophenol 
• 7722-84-1 dihydrogen peroxide 
• 93249-29-7 benzenesulfonylacetyl-urea 
• 71560-75-3 1,3-bis(benzenesulfonyl)propan-2-one 
• 20611-21-6 2-(phenylsulfonyl)ethanol 
• 7664-93-9 sulfuric acid 
• 873-55-2 sodium benzenesulfonate 
• 79-11-8 chloroacetic acid 
• 34097-60-4 methyl benzenesulfonylacetate 

Downstream Products

• 78440-47-8 7-acetoxy-3-benzenesulfonyl-coumarin 
• 102582-87-6 Benzenesulfonyl-acetic acid; compound with 2-[bis-(2-hydroxy-ethyl)-amino]-ethanol 
• 80422-10-2 N,N'-Diphenylacetamidinium-2-(phenylsulfonyl)acetat 
• 80421-05-2 N,N'-Diphenylformamidinium-2-(phenylsulfonyl)acetat 
• 1026704-79-9 2-Benzenesulfonyl-1-(2-ethyl-2,3-dihydro-indol-1-yl)-ethanone 
• 201045-71-8 Acetic acid (Z)-4-[(2-benzenesulfonyl-acetyl)-benzyl-amino]-but-2-enyl ester 
• 20018-08-0 diiodomethyl-phenyl sulfone 
• 56361-12-7 (E)-4-bromostyryl phenyl sulfone 
• 1360789-21-4 2-(phenylsulfonyl)-1-(2,2,6,6-tetramethylpiperidin-1-yl)ethanone 
• 1360789-13-4 N-(tert-butyl)-N-ethyl-2-(phenylsulfonyl)acetamide 
• 1360789-17-8 N-(tert-butyl)-N-isopropyl-2-(phenylsulfonyl)acetamide 
• 1360789-26-9 2-(phenylsulfonyl)-1-(2,2,6,6-tetramethylpiperidin-1-yl)propan-1-one 
• 118621-31-1 phenyl 2-(phenylsulfonyl)acetate 
• 1360789-25-8 S-phenyl 2-(phenylsulfonyl)ethanethioate 

Relevant articles and documents

COMPOSITES, METHODS AND USES THEREOF

The present invention relates, in general terms, to methods of catalysing a reaction, including the steps of contacting a chemical entity comprising a sulphide moiety with a composite and an oxidant. The composite acts as a heterogeneous catalyst to oxidise the sulphide moiety. The present invention also relates to composites, methods of synthesising the composites and its use as a catalyst thereof.

Chromone 3-position nitric oxide donor derivative as well as preparation method and application thereof

The invention relates to the fields of natural medicines and medicinal chemistry, and relates to a preparation method of a series of chromone 3-position nitric oxide donor derivatives with antitumor activity and a new application of the chromone 3-position nitric oxide donor derivatives in preparation of antitumor medicines. The chromone 3-position nitric oxide donor derivative and the pharmaceutically acceptable salt thereof are shown as a general formula I in the specification. Wherein R and R1 are described in the claims and the specification.

Chromone 2-position nitric oxide donor derivative as well as preparation method and application thereof

The invention relates to the fields of natural medicines and medicinal chemistry, and relates to a preparation method of a series of chromone 2-position nitric oxide donor derivatives with antitumor activity and a new application of the chromone 2-position nitric oxide donor derivatives in preparation of antitumor medicines. The chromone 2-position nitric oxide donor derivative and the pharmaceutically acceptable salt thereof are shown as a general formula I in the specification. Wherein R and R1 are described in the claims and the specification.